Search
for
Sort by
Research 151–180 of 349
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Dermatological Manifestations of Patients with COVID 19: A Cross-sectional study
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Insights into disparities observed with COVID‐19
- Androgen sensitivity gateway to COVID‐19 disease severity
- Coronavirus Infection and Cholesterol Metabolism
- Targeting integrin pathways: mechanisms and advances in therapy
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- The immune response to COVID‐19: Does sex matter?
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Repurposed Drugs: Current Trends in Drug Discovery
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
- Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Targeted Self-Assembled anti-NFκB AuNCs-Aptamer Nanoplatform for Precise Theranostics via Tailored Follicle Regeneration
- Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- COVID-19: The question of genetic diversity and therapeutic intervention approaches